**6. Conclusions and future perspectives**

Medicinal plants are potential source of various chemical constitutes which are responsible for the cure of different diseases. Scientific work of these plants is based on the ethnopharmacological use, largely based on trial and error, which may cause harm to humans. In addition, there is a false public perception that natural remedies are free of side or toxic effects. Although this claim is correct to some extent due to the presence of agonist and antagonist molecules in the same plant or extract, however, use of such chemical constitutes without scientific knowledge could lead to serious health problems. For this reason, researchers have tested these alternative medicines for various disorders. Within this context, the genus *Pistacia* has been screened for different diseases based on ethnomedicinal uses. In the present work, we tried to collect all pharmacological data related to *Pistacia*. The wide spread use of members of this genus made it a key source of natural medicines. Furthermore, the purpose of this data collection was to encourage researchers for development and commercialization of these valuable members into various dosage forms.

The genus *Pistacia* accumulated many potential plants with significantly correlated activities such as analgesic, anti-inflammatory, nephroprotective, hepatoprotective, and anti-peptic ulcers. These activities are positively correlated because most of the NSAIDs cause hepatic, renal and stomach problems. So plants in this genus are tested on such an experimental model. The same animal is subjected to pain, inflammation, peptic ulcers, hepatitis and nephrotic damages and then treated with these plants individually or in a mixture with the hope to cure with time. If the researcher succeeded in such a study, it would be a breakthrough in pharmaceutical sciences to minimize polypharmacy. It is worth mentioning that the plants of this genus are anti-diabetic, neuroprotective, anti-diabetic wound, GLUT enhancer, lipid-lowering and anti-HTN. All these conditions have a significant correlation. A substantial number of patients worldwide suffered at times with these conditions. Therefore, we strongly recommend these plants be tested up to the clinical trial level for curing such diseases. The significant curing of such correlated disorders can abolish the problem of polypharmacy. Polypharmacy is one of the major factors leading to poor patient compliance. Moreover, chronic toxicological profiling of these plants is needed on all vital organs.

*Pharmacological Investigation of Genus* Pistacia *DOI: http://dx.doi.org/10.5772/intechopen.97322*
